Scientists’ AMR warning over government’s new ‘pharmacy-first’ policy – letter

  17 May 2023

Dear Prime Minister,

We applaud the government’s initiative of empowering community pharmacists to prescribe medicines for some common illnesses in order to reduce GP workload, cut waiting lists and alleviate the pressure on the NHS.

However, we strongly caution the government that unless it is implemented with due consideration given to antibiotic resistance, such an initiative could lead to unintended consequences that would reverse the gains it makes.

Antibiotic resistance describes the situation when bacterial infections no longer respond to the antibiotic medicines used against them. It has already been estimated to cause over one million deaths worldwide in 2019; if no action is taken, this toll may rise to 10 million by 2050, resulting in a cumulative cost of $100 trillion (equal to last year’s global GDP) to the world economy.

Further reading: The Telegraph
Author(s): Till Bachmann et al
Effective Surveillance   Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed